CompaniesMycenax Biotech

Mycenax Biotech

active
Zhubei, Taiwan
Founded 2001
Website
About

CDMO, Biosimilars

Areas of Focus

Categories

BiosimilarsContract ManufacturingContract ManufacturingContract ManufacturingContract ResearchContract ResearchContract ResearchContract ResearchContract ManufacturingContract ResearchContract ManufacturingContract ManufacturingTaiwan
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

389

By Phase

PHASE1: 1PHASE3: 3

By Status

UNKNOWN: 2COMPLETED: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
NCT01709760
NCT01787149
NCT02685904
Hover over trial bars to see details

Recent Trials

NCT03522012Lead Sponsor
Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers
PHASE1Completed
190 participants
Started: Oct 17, 2017 · Completed: Dec 20, 2018
NCT02685904Lead Sponsor
A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis
PHASE3Terminated
10 participants
Started: Sep 6, 2016 · Completed: Dec 31, 2018
NCT01787149Lead Sponsor
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis
PHASE3Unknown
98 participants
Started: Sep 30, 2013 · Completed: Dec 31, 2019
NCT01709760Lead Sponsor
A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA
PHASE3Unknown
91 participants
Started: Nov 30, 2012 · Completed: Dec 31, 2019
Locations (1)
Headquarters
Zhubei, Taiwan
Map

Loading map...